425: Strive CMO Reposts Merger Update with Semler Scientific

Strive's Chief Marketing Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are pursuing a proposed business combination.
• The communication, reposted by Arshia Sarkhani, Strive's Chief Marketing Officer, on September 22, 2025, serves as a cautionary statement regarding forward-looking statements related to the merger.
• Forward-looking statements include expectations for the proposed transaction, strategic and financial benefits, impact on combined company's future financial performance, timing of closing, and ability to integrate businesses.
• The filing emphasizes that actual results could differ materially from anticipated results due to various risks and uncertainties.
• Investors are urged to read the Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, for important information about the companies and the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a merger, outlining potential benefits but heavily emphasizing numerous risks and uncertainties. It does not present new financial results but rather legal disclosures, leading to a neutral to slightly cautious sentiment.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected from the proposed transaction, including a positive impact on future financial performance.
• The ability to successfully integrate the combined businesses is a stated objective.

Negatives

• The proposed transaction may not close when expected or at all if conditions to closing are not met.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships could occur.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the transaction.

Risks

• Occurrence of any event, change, or circumstances that could give rise to the right of either party to terminate the merger agreement.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• Outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized due to changes in or problems arising from Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook and expectations for Strive and Semler Scientific regarding the proposed transaction include anticipated strategic and financial benefits, a positive impact on the combined company's future financial performance, and successful integration of the businesses. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., reposted the communication on X.com regarding the proposed business combination.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that the combined entity may be engaging with or exposed to the evolving trend of corporate adoption of digital assets for treasury management, a significant development in the financial and corporate sectors.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of both companies face risks from potential changes in share price before closing.
• Customers and employees of both Strive and Semler Scientific may experience adverse reactions or changes to business/employee relationships as a result of the merger announcement or completion.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.

Key Dates

Recommendation

This filing is a standard cautionary statement regarding a proposed business combination, not a report on financial performance. It highlights the inherent risks and uncertainties associated with mergers, including potential delays, integration challenges, and dilution. While the underlying merger event is significant, this specific document primarily serves as a legal disclosure of risks rather than a catalyst for immediate investment action. Investors should hold their positions and await further detailed information, particularly the definitive Information Statement/Proxy Statement/Prospectus, before making new investment decisions.

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin treasury strategies, digital assets, corporate governance, risk management